Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.
Jama Oncology
Cobain, Erin F EF; Wu, Yi-Mi YM; Vats, Pankaj P; Chugh, Rashmi R; Worden, Francis F; Smith, David C DC; Schuetze, Scott M SM; Zalupski, Mark M MM; Sahai, Vaibhav V; Alva, Ajjai A; Schott, Anne F AF; Caram, Megan E V MEV; Hayes, Daniel F DF; Stoffel, Elena M EM; Jacobs, Michelle F MF; Kumar-Sinha, Chandan C; Cao, Xuhong X; Wang, Rui R; Lucas, David D; Ning, Yu Y; Rabban, Erica E; Bell, Janice J; Camelo-Piragua, Sandra S; Udager, Aaron M AM; Cieslik, Marcin M; Lonigro, Robert J RJ; Kunju, Lakshmi P LP; Robinson, Dan R DR; Talpaz, Moshe M; Chinnaiyan, Arul M AM
Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies.
Jco Precision Oncology
Kato, Shumei S; Okamura, Ryosuke R; Mareboina, Manvita M; Lee, Suzanna S; Goodman, Aaron A; Patel, Sandip P SP; Fanta, Paul T PT; Schwab, Richard B RB; Vu, Peter P; Raymond, Victoria M VM; Lanman, Richard B RB; Sicklick, Jason K JK; Lippman, Scott M SM; Kurzrock, Razelle R
A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.
The Oncologist
Vasan, Neil N; Yelensky, Roman R; Wang, Kai K; Moulder, Stacy S; Dzimitrowicz, Hannah H; Avritscher, Rony R; Wang, Baliang B; Wu, Yun Y; Cronin, Maureen T MT; Palmer, Gary G; Symmans, W Fraser WF; Miller, Vincent A VA; Stephens, Philip P; Pusztai, Lajos L